ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 344,750
+39,750 (13.03%)
Aug 10, 2026, 9:42 AM KST
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 21.24 trillion as of August 7, 2026. Its market cap has decreased by -9.58% in one year.
Market Cap
21.24T
Enterprise Value
20.90T
Revenue
203.76B
Ranking
n/a
PE Ratio
202.28
Stock Price
344,750.00
ChartMarket Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 21.24T, an increase of 17,604.53%. That is a compound annual growth rate of 55.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 21.24T | -11.66% |
| Dec 30, 2025 | 24.04T | 45.74% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.03T |
| Celltrion | 45.70T |
| Samsung Epis Holdings | 10.22T |
| SK Biopharmaceuticals | 6.69T |
| HLB Co., Ltd. | 4.96T |
| ABL Bio | 4.85T |
| Peptron | 4.24T |
| LigaChem Biosciences | 4.17T |